 |
|
|
|
TRIAMCINOLONE ACETONIDE TABLETS Reference Page
Description
Highly potent synthetic glucocorticoid and anti-inflammatory agent for treatment of inflammation and related disorders in dogs and cats.
Features
- Few sodium-retaining effects.
- Equal anti-inflammatory effects.
- Treat-to-effect dosage.
Benefits
- Less water retention.
- Comparable anti-inflammatory effects as older corticosteroids with a lower dose.
- After initial suppressive dose level has been administered and satisfactory response obtained, the daily dose can be reduced to the minimal effective maintenance dose level.
Advantages
Highly effective anti-inflammatory for dogs and cats exhibiting fewer sodium-retaining effects while providing comparable anti-inflammatory effects as older corticosteroids.
Dosage & Administration
As with other steroids, Triamcinolone Acetonide treatment should be individualized based on severity of disease, anticipated duration of therapy and the animalís tolerance for steroid excess. The initial suppressive dose level of 0.5 to 1.0 mg per 10 lbs of bodyweight daily should be administered until a satisfactory clinical response is obtained, a period not to exceed 14 days. If a satisfactory response is not obtained in 14 days, re-evaluation of the case to confirm the original diagnosis should be made. As soon as a satisfactory response is obtained, the daily dose should be reduced gradually. See insert for complete information.
Precautions
Because of its inhibitory effect on fibroplasia, triamcinolone may mask the signs of infection and enhance dissemination of the infecting organism. Hence, all animals receiving triamcinolone should be watched for evidence of intercurrent infection. Should infection occur, it must be brought under control by use of appropriate antibacterial measures or administration of triamcinolone should be discontinued.
Because this anti-inflammatory steroid manifests little sodium-retaining activity, the usual early sign of cortisone or hydrocortisone overdosage is not a reliable index of overdosage.
Use of corticosteroids may result in the inhibition of endogenous steroid production, which sometimes persist for weeks following drug withdrawal. In patients presently receiving or recently withdrawn from corticosteroid treatments, administration of a rapid acting, corticosteroid before, during and after an unusually stressful situation is recommended.
Uses
Triamcinolone Acetonide Tablets are indicated in the management and treatment of acute arthritis and allergic and dermatologic disorders.
Warning
Not for human use.
Clinical and experimental data have demonstrated that corticosteroids administered orally or parenterally to animals may induce the first stage of parturition when administered during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta and metritis. Additionally corticosteroids administered during pregnancy have produced cleft palate. Side effects and metabolic alterations can be anticipated when treatment is intensive or prolonged in animals with diabetes mellitus. See insert for complete information.
Product Information
|
Name
|
Code
|
Size
|
|
TRIAMCINOLONE ACETONIDE TABLETS
|
687-655
|
1000s
|
|
TRIAMCINOLONE ACETONIDE TABLETS
|
687-635
|
500s
|
|
-
|
-
|
-
|
|
-
|
-
|
-
|
|
-
|
-
|
-
|
Highlights
- Treat-to-effect dosage
- Less water retention
- Two size presentations
Contact Information
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway
St. Joseph, MO 64506
Information: 800-821-7467
Sales: 800-325-9167
Fax: 816-236-2717
email: techservices-ca@bi-vetmedica.com
internet: http://www.bi-vetmedica.com
General Product Information Documents
Product Photos and Product Art
|
|
|
|
|
